Page last updated: 2024-11-02

phenylbutazone and Congenital Thrombotic Thrombocytopenic Purpura

phenylbutazone has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunea, G1
Muehrcke, RC1
Nakamoto, S1
Schwartz, FD1

Other Studies

1 other study available for phenylbutazone and Congenital Thrombotic Thrombocytopenic Purpura

ArticleYear
Thrombotic thrombocytopenic purpura with acute anuric renal failure.
    The American journal of medicine, 1966, Volume: 41, Issue:6

    Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Anuria; Diagnosis, Differential; Female; Humans; Phen

1966